Latest filings (excl ownership)
CT ORDER
Confidential treatment order
29 Dec 11
EFFECT
Notice of effectiveness
18 Jan 11
EFFECT
Notice of effectiveness
18 Jan 11
EFFECT
Notice of effectiveness
18 Jan 11
EFFECT
Notice of effectiveness
18 Jan 11
15-12G
Securities registration termination
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
POS AM
Prospectus update (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Jan 11
25-NSE
Exchange delisting
13 Jan 11
SC TO-T/A
Third party tender offer statement (amended)
6 Jan 11
SC 14D9/A
Tender offer solicitation (amended)
4 Jan 11
SC TO-T/A
Third party tender offer statement (amended)
4 Jan 11
SC 14D9/A
Tender offer solicitation (amended)
30 Dec 10
SC 14D9/A
Tender offer solicitation (amended)
29 Dec 10
8-A12B/A
Registration of securities on exchange (amended)
22 Dec 10
8-K
Departure of Directors or Certain Officers
22 Dec 10
SC 14D9/A
Tender offer solicitation (amended)
21 Dec 10
SC TO-T/A
Third party tender offer statement (amended)
21 Dec 10
SC TO-T/A
Third party tender offer statement (amended)
20 Dec 10
8-K
Entry into a Material Definitive Agreement
16 Dec 10
8-K
Cypress Bioscience Agrees to Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share In Cash
15 Dec 10
SC TO-T/A
Third party tender offer statement (amended)
15 Dec 10
SC TO-T/A
Third party tender offer statement (amended)
14 Dec 10
UPLOAD
Letter from SEC
13 Dec 10
UPLOAD
Letter from SEC
13 Dec 10
SC TO-T/A
Third party tender offer statement (amended)
10 Dec 10
UPLOAD
Letter from SEC
15 Nov 10
10-Q
2010 Q3
Quarterly report
9 Nov 10
8-K
Results of Operations and Financial Condition
9 Nov 10
Latest ownership filings
SC 13D
RP Management, LLC
23 Dec 10
SC 13D/A
Ramius Value & Opportunity LLC
20 Dec 10
SC 13D/A
RA CAPITAL MANAGEMENT, LLC
30 Sep 10
SC 13D/A
Ramius LLC
20 Sep 10
SC 13D/A
Ramius LLC
16 Sep 10
SC 13D
RA CAPITAL MANAGEMENT, LLC
13 Sep 10
SC 13D/A
Ramius LLC
12 Aug 10
SC 13D/A
Ramius LLC
6 Aug 10
SC 13D/A
Ramius LLC
22 Jul 10
SC 13D
Ramius LLC
19 Jul 10